Global Pharmaceutical Markets: Country Overviews for the Pharmaceutical Industry

US: 800.298.5699

Int'l: +1.240.747.3093

Research Assistance

Send us a request >

Start New Browse

Food & Beverage

Marketing & Market Research

Service Industries

Technology & Media

Company Reports

Country Reports

View all Market Areas

View all Publishers

Latest Research by Email

Receive email alerts of new market research reports in your industry.

Sign Up Today >

Home > Life Sciences > Pharmaceuticals > Country Overviews

Life Sciences

Life Sciences

Country Overviews of Pharmaceutical Markets and Industries

Find the information you need on pharmaceutical country overviews. Our collection of market research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets.

< prev 1 2 3 4 5 6 7 8 9 10 next >

Use column headings to sort

Title	Published	Price
Snapshots Spain Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Spain Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Spanish pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Snapshots Poland Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Poland Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Polish pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Snapshots Hungary Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Hungary Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Hungarian pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Snapshots Venezuela Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Venezuela Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Venezuelan pharmaceutical market and \| more... Search inside this report	11/12/2009	$600.00
Snapshots South Africa Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots South Africa Pharmaceuticals 2009 provides 2008 year-end market size data, with 2009 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the South African pharmaceutical \| more... Search inside this report	11/12/2009	$600.00
Poland Pharmaceuticals and Healthcare Report Q1 2010 By: Business Monitor International Poland is one of the highest value markets in Central and Eastern Europe (CEE) and as a result is adestination for almost all multinationals operating within the region. Poland’s pharmaceutical market hasshown consistently strong growth \| more... Search inside this report	11/10/2009	$495.00
Argentina Pharmaceuticals and Healthcare Report Q1 2010 By: Business Monitor International The value of Argentina’s pharmaceutical market in 2008 was US$3.7bn. BMI’s updated forecasts see themarket reaching a value of US$6.12bn by 2014, representing a compound annual growth rate (CAGR) of12.68% in US dollar terms. With \| more... Search inside this report	11/10/2009	$495.00
Australia Pharmaceuticals and Healthcare Report Q1 2010 By: Business Monitor International Australia’s pharmaceutical market is among the most developed in the Asia-Pacific region. Access tomedication is good across all sections of the population, with per-capita spending calculated at US$352 in2008. While not particularly high by Western \| more... Search inside this report	11/10/2009	$495.00
Kenya Pharmaceuticals and Healthcare Report Q1 2010 By: Business Monitor International BMI’s proprietary Drug Expenditure Forecast Model reveals that the Kenyan pharmaceutical market willreturn to a double-digit growth rate in 2009 (in local currency terms), after declining to single-digitgrowth the previous year. During 2008, OTC and \| more... Search inside this report	11/10/2009	$495.00
Thailand Pharmaceuticals and Healthcare Report Q1 2010 By: Business Monitor International In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth totenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing andageing population represents a substantial commercial opportunity \| more... Search inside this report	11/10/2009	$495.00
Nigeria Pharmaceuticals and Healthcare Report Q1 2010 By: Business Monitor International The value of Nigeria’s pharmaceutical market in 2008 was NGN80.9bn (US$680mn). We forecast a12.8% year-on-year (y-o-y) growth in local currency during 2009, expecting that the market will grow bya compound annual growth rate (CAGR) of \| more... Search inside this report	11/10/2009	$495.00
Romania - Health Care Report By: TrendsSpotting.com Romania - Health Care Report offers a comprehensive review of the current state of the Romanian health care system, the pharmaceutical industry and the medical equipment market. It provides a business perspective on private and \| more... Search inside this report	11/1/2009	$250.00
Pharmaceutical Industry in Mexico By: Aruvian's R'search Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease. Mexico’s pharmaceutical policy environment is in a period of \| more... Search inside this report	11/1/2009	$275.00
Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis By: Aruvian's R'search Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. \| more... Search inside this report	11/1/2009	$175.00
Lebanon Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International We expect total drug spending in Lebanon to increase from under US$500mn in 2008 to US$605mn in2013, a compound annual growth rate (CAGR) of 3.9% in US dollar terms, with 1.75% of GDP dedicatedto pharmaceutical \| more... Search inside this report	10/21/2009	$495.00
Belarus Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International A brief recession and the devaluation of the local currency have demonstrated that Belarus has not beenable to escape the global economic crisis, although sheer lack of integration into the global financialsystem has done much \| more... Search inside this report	10/21/2009	$495.00
Portugal Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International BMI calculates that pharmaceutical sales in Portugal reached EUR3.61bn (US$5.31bn) in 2008. Wecalculate that the sales of prescription and over-the-counter (OTC) medicines will reach a value ofEUR0.302bn by 2013, equating to a constant annual growth \| more... Search inside this report	10/15/2009	$495.00
China Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International In BMI’s view, China is arguably the most attractive emerging pharmaceutical market. Though to 2013,we are forecasting a compound annual growth rate (CAGR) of 15.45%. Annual per-capita spending willrise from US$27.60 to US$54.40. Spending as \| more... Search inside this report	10/15/2009	$495.00
Bahrain Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International From BHD44mn (US$114mn) in 2008, BMI forecasts that Bahrain’s pharmaceutical market will expandto be worth BHD61mn (US$160mn) in 2018. While the market will remain small in absolute terms, rapidvalue growth, representing a compound annual growth \| more... Search inside this report	10/15/2009	$495.00
South Africa Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International We expect the value of the total pharmaceutical market to increase from US$2.5bn in 2008 to US$4.2bnby 2013, representing a compound annual growth rate (CAGR) of 10.8% in US dollar terms and 8.6% inlocal currency. \| more... Search inside this report	10/14/2009	$495.00
Lithuania Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International BMI calculates that Lithuania’s pharmaceutical market reached a value of LTL1.70bn (US$0.70bn) in2008. By 2013, we expect the value of the prescription and over-the-counter (OTC) markets to reach avalue of LTL2.13bn, equating to a compound \| more... Search inside this report	10/14/2009	$495.00
Venezuela Pharmaceuticals and Healthcare Report Q4 2009 By: Business Monitor International BMI calculates that pharmaceutical sales in Venezuela reached VEB7.5bn (US$3.57bn) in 2008. By2013, we forecast the Venezuelan pharmaceutical market will be worth VEB26.0bn, increasing at acompound annual growth rate (CAGR) of 28.23%. BMI notes that \| more... Search inside this report	10/14/2009	$495.00
Snapshots France Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots France Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the French pharmaceutical market and \| more... Search inside this report	10/12/2009	$600.00
Snapshots Bulgaria Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Bulgaria Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Bulgarian pharmaceutical market and \| more... Search inside this report	10/12/2009	$600.00
Snapshots Australia Pharmaceuticals 2009 By: Snapdata International Group Snapdata's Snapshots Australia Pharmaceuticals 2009 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report gives an instant overview of the Australian pharmaceutical market and \| more... Search inside this report	10/12/2009	$600.00
Title	Published	Price

< prev 1 2 3 4 5 6 7 8 9 10 next >

Privacy Policy | Terms and Conditions | Site Map | Return Policy | Press | Help FAQs

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/25/2009 - 3